Northwestern Team Identifies Tau Hotspot, and a Chemical Tag on It Stops Fibril Growth in Lab Tests

Researchers at Northwestern University and the University of California, Santa Barbara say they have found the spot on tau protein where the trouble starts.

Tau normally helps stabilize the internal scaffolding of nerve cells. In Alzheimer's disease and frontotemporal dementia it misfolds, then pulls other tau molecules into the same bad shape. The result is long fibrils that pile up inside neurons as tangles and disrupt communication between nerve cells.

How a floppy, unstructured protein manages to find its partners and stack with perfect alignment has been a black box. The new paper, published in the Proceedings of the National Academy of Sciences (DOI 10.1073/pnas.2611158123), offers a specific answer.

One dominant hotspot

The team, led by Northwestern chemist Songi Han, found that aggregation-prone tau carries a single dominant hotspot. That site binds a matching site on a neighboring tau molecule, or on the tau sitting at the end of an existing fibril. The incoming molecule then misfolds to match.

Han is the Mark and Nancy Ratner Professor of Chemistry at Northwestern's Weinberg College of Arts and Sciences. She is the senior author.

To find the site, the researchers tracked shortened, engineered lengths of tau as they met pre-existing tau fibers. They used nuclear magnetic resonance spectroscopy to watch individual regions of the protein as it clumped.

A region around amino acid 300 made contact with existing aggregates faster than the other sites examined. The team calls the sequence "dock-and-lock": tau docks at a preferred contact point, then locks in as the rest of the molecule lines up with the fiber.

Water does the work

Protein structure alone did not explain the stickiness. Molecular simulations and water-dynamics experiments showed the hotspot sits in a hydrophobic region, one that repels water, and that water molecules form a dynamic cap over it.

When two matching hotspots meet, the water is released. According to the researchers, the energy from that release helps pull the two proteins together and into alignment.

Alignment matters because fibril growth depends on it. "If you have a tiny mismatch in the alignment of the tau shapes that stack to the fibril end, the structure will eventually stop growing," Han said. She compared the stacking to a tower of poker chips thousands high.

The tag test

The researchers attached a chemical tag to the hotspot, and fibril growth stopped. They also tagged two other sites away from the hotspot, and growth continued.

That contrast is the core of the finding. It indicates the hotspot is not just one of many places tau can latch on, but a site the process depends on.

"Once you know that aggregation-prone tau proteins always have a hotspot that is first attracted to the same site of tau that is stacked to fibrils, then you know there's always some part of the protein that you can target to neutralize," Han said. "If you know where to block its action of misfolding, you could block it to prevent it from propagating."

Han also described the result as a possible shortcut for drug hunters. "Instead of searching for everything, we can say, 'Look for that hotspot. That's the spot that matters,'" she said.

What this does and does not show

The work was done in a lab, with engineered tau fragments and chemical tags. It was not done in a living brain.

No drug has been designed or tested against the hotspot. The experiments do not show that blocking the site slows disease, improves symptoms, or prevents tau from spreading in people.

The authors point to three potential uses: better diagnostics for tauopathies, therapies that block misfolded tau from converting normal tau, and laboratory models that reproduce different tau-related diseases. These are goals, not results.

The paper is reaching the public in stages. Reporting on the study places its first appearance in PNAS on Oct. 12, with the full study still to follow on Oct. 16.

What comes next

The open question is practical. A chemical tag in a test tube is a long way from a molecule that can reach the hotspot inside neurons, stay there, and do no harm elsewhere.

The hotspot is hydrophobic and wrapped in water. That is the property the team says drives the process, and it is also what any drug candidate would have to work against.

Whether other labs can reproduce the tag result, and whether a drug-like compound can mimic it, will determine if this stays a basic chemistry finding or becomes a drug target.